PGFC
IDXX icon

Peapack-Gladstone Financial Corp’s Idexx Laboratories IDXX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Sell
724
-99
-12% -$55.5K ﹤0.01% 555
2026
Q1 		$462K Sell
823
-48
-6% -$30.8K 0.01% 513
2025
Q4 		$589K Sell
871
-1
-0.1% -$681 0.01% 468
2025
Q3 		$557K Buy
872
+18
+2% +$10.9K 0.01% 484
2025
Q2 		$458K Buy
+854
New +$408K 0.01% 491

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Peapack-Gladstone Financial Corp's IDXX Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp reduced its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, selling an estimated $55.5K and leaving 724 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Peapack-Gladstone Financial Corp first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $589K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 724 shares of Idexx Laboratories worth $381K as of Q2 2026.
  • Peapack-Gladstone Financial Corp sold 99 Idexx Laboratories shares in Q2 2026, an estimated $55.5K.
  • Idexx Laboratories made up ﹤0.01% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #555 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Peapack-Gladstone Financial Corp's Idexx Laboratories position peaked at $589K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.